Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-78c5997874-g7gxr Total loading time: 0 Render date: 2024-11-17T15:00:02.116Z Has data issue: false hasContentIssue false

Chapter 11 - Management of cognitive impairment in Parkinson's disease

from Section II - Management of Nonmotor Symptoms of Parkinson's Disease

Published online by Cambridge University Press:  05 March 2016

By
Dawn M. Schiehser ,
Eva Pirogovsky-Turk  and
Irene Litvan
Edited by
Néstor Gálvez-Jiménez ,
Hubert H. Fernandez ,
Alberto J. Espay  and
Susan H. Fox
Néstor Gálvez-Jiménez
Affiliation:
Cleveland Clinic, Florida
Hubert H. Fernandez
Affiliation:
Cleveland Clinic, Ohio
Alberto J. Espay
Affiliation:
University of Cincinnati
Susan H. Fox
Affiliation:
Toronto Western Hospital
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Parkinson's Disease
Current and Future Therapeutics and Clinical Trials
 , pp. 111 - 121
Publisher: Cambridge University Press
Print publication year: 2016

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Aarsland, D, Zaccai, J, Brayne, C. A systematic review of prevalence studies of dementia in Parkinson's disease. Mov Disord 2005; 20: 1255–63.CrossRefGoogle ScholarPubMed
Aarsland, D, Andersen, K, Larsen, JP, Lolk, A, Kragh-Sorensen, P. Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch Neurol 2003; 60: 387–92.Google Scholar
Aarsland, , , D, Karlsen, K. Neuropsychiatric aspects of Parkinson's disease. Curr Psychiatry Rep 1999; 1: 61–8.Google Scholar
Hughes, TA, Ross, HF, Mindham, RH, Spokes, EG. Mortality in Parkinson's disease and its association with dementia and depression. Acta Neurol Scand 2004; 110: 118–23.Google Scholar
Muslimovic, D, Post, B, Speelman, JD, De Haan, RJ, Schmand, B. Cognitive decline in Parkinson's disease: a prospective longitudinal study. J Int Neuropsychol Soc 2009; 15: 426–37.Google Scholar
Goldman, JG, Litvan, I. Mild cognitive impairment in Parkinson's disease. Minerva Med 2011; 102: 441–59.Google Scholar
Litvan, I, Aarsland, D, Adler, CH, et al. MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI. Mov Disord 2011; 26: 1814–24.Google Scholar
Aarsland, D, Bronnick, K, Williams-Gray, C, et al. Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis. Neurology 2010; 75: 1062–9.CrossRefGoogle ScholarPubMed
Janvin, CC, Larsen, JP, Aarsland, D, Hugdahl, K. Subtypes of mild cognitive impairment in Parkinson's disease: progression to dementia. Mov Disord 2006; 21: 1343–9.Google Scholar
Mamikonyan, E, Moberg, PJ, Siderowf, A, et al. Mild cognitive impairment is common in Parkinson's disease patients with normal Mini-Mental State Examination (MMSE) scores. Parkinsonism Relat Disord 2009; 15: 226–31.Google Scholar
Woods, SP, Tröster, AI. Prodromal frontal/executive dysfunction predicts incident dementia in Parkinson's disease. Journal of the International Neuropsychological Society 2003; 9: 17–24.Google Scholar
Owen, AM. Cognitive dysfunction in Parkinson's disease: the role of frontostriatal circuitry. Neuroscientist 2004; 10: 525–37.Google Scholar
Zgaljardic, DJ, Borod, JC, Foldi, NS, Mattis, P. A review of the cognitive and behavioral sequelae of Parkinson's disease: relationship to frontostriatal circuitry. Cogn Behav Neurol 2003; 16: 193–210.Google Scholar
Zgaljardic, DJ, Borod, JC, Foldi, NS, et al. An examination of executive dysfunction associated with frontostriatal circuitry in Parkinson's disease. J Clin Exp Neuropsychol 2006; 28: 1127–44.Google Scholar
Filoteo, JV, Maddox, WT. Quantitative modeling of visual attention processes in patients with Parkinson's disease: effects of stimulus integrality on selective attention and dimensional integration. Neuropsychology 1999; 13: 206–22.Google Scholar
Gabrieli, JD, Singh, J, Stebbins, GT, Goetz, CG. Reduced working memory span in Parkinson’ disease: evidence for the role of a frontostriatal system in working and strategic memory. Neuropsychology 1996 10: 322–32.Google Scholar
Owen, AM, Sahakian, BJ, Hodges, JR, Summers, BA. Dopamine-dependent frontostriatal planning deficits in early Parkinson's disease. Neuropsychology 1995; 9: 126–40.Google Scholar
Richards, M, Cote, LJ, Stern, Y. Executive function in Parkinson's disease: set-shifting or set-maintenance? J Clin Exp Neuropsychol 1993; 15: 266–79.CrossRefGoogle ScholarPubMed
Filoteo, JV, Rilling, LM, Cole, B, et al. Variable memory profiles in Parkinson's disease. J Clin Exp Neuropsychol 1997; 19: 878–88.CrossRefGoogle ScholarPubMed
Weintraub, D, Moberg, PJ, Culbertson, WC, et al. Dimensions of executive function in Parkinson's disease. Dement Geriatr Cogn Disord 2005; 20: 140–4.Google Scholar
Higginson, CI, King, DS, Levine, D, et al. The relationship between executive function and verbal memory in Parkinson's disease. Brain Cogn 2003; 52: 343–52.Google Scholar
Taylor, AE, Saint-Cyr, JA, Lang, AE. Memory and learning in early Parkinson's disease: evidence for a “frontal lobe syndrome”. Brain Cogn 1990; 13: 211–32.Google Scholar
Levin, BE, Llabre, MM, Reisman, S, et al. Visuospatial impairment in Parkinson's disease. Neurology 1991; 41: 365–9.CrossRefGoogle ScholarPubMed
Montse, A, Pere, V, Carme, , J, Francesc, , V, Eduardo, T. Visuospatial deficits in Parkinson's disease assessed by judgment of line orientation test: error analyses and practice effects. J Clin Exp Neuropsychol 2001; 23: 592–8.Google Scholar
Emre, M. Dementia associated with Parkinson's disease. Lancet Neurol 2003; 2: 229–37.CrossRefGoogle ScholarPubMed
McPherson, S, Cummings, J. Neuropsychological aspects of Parkinson's disease and Parkinsonism. In Grant, I, Adams, KA, eds. Neuropsychological Assessment of Neuropsychiatric and Neuromedical Disorders. New York: Oxford University Press, 2009; 199–222.Google Scholar
Litvan, I, Mohr, E, Williams, J, Gomez, C, Chase, TN. Differential memory and executive functions in demented patients with Parkinson's and Alzheimer's disease. J Neurol Neurosurg Psychiatry 1991; 54: 25–9.CrossRefGoogle ScholarPubMed
Pillon, B, Dubois, B, Ploska, A, Agid, Y. Severity and specificity of cognitive impairment in Alzheimer's, Huntington's, and Parkinson's diseases and progressive supranuclear palsy. Neurology 1991; 41: 634–43.Google Scholar
Stern, Y, Marder, K, Tang, MX, Mayeux, R. Antecedent clinical features associated with dementia in Parkinson's disease. Neurology 1993; 43: 1690–2.Google Scholar
Ferreira, JJ, Katzenschlager, R, Bloem, BR, et al. Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease. Eur J Neurol 2013; 20: 5–15.Google Scholar
Hanagasi, HA, Gurvit, H, Unsalan, P, et al. The effects of rasagiline on cognitive deficits in Parkinson's disease patients without dementia: a randomized, double-blind, placebo-controlled, multicenter study. Mov Disord 2011; 26: 1851–8.Google Scholar
Emre, M, Aarsland, D, Albanese, A, et al. Rivastigmine for dementia associated with Parkinson's disease. N Engl J Med 2004; 351: 2509–18.Google Scholar
Dubois, B, Tolosa, E, Katzenschlager, R, et al. Donepezil in Parkinson's disease dementia: a randomized, double-blind efficacy and safety study. Mov Disord 2012; 27: 1230–8.Google Scholar
Emre, M, Tsolaki, M, Bonuccelli, U, et al. Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial. Lancet Neurol 2010; 9: 969–77.Google Scholar
Aarsland, D Ballard, C, Walker, Z, et al. Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial. Lancet Neurol 2009; 8: 613–18.Google Scholar
Cerasa, A, Gioia, MC, Salsone, M, et al. Neurofunctional correlates of attention rehabilitation in Parkinson's disease: an explorative study. Neurol Sci 2014; 35: 1173–80.Google Scholar
Disbrow, EA, Russo, KA, Higginson, CI, et al. Efficacy of tailored computer-based neurorehabilitation for improvement of movement initiation in Parkinson's disease. Brain Res 2012; 1452: 151–64.Google Scholar
Mohlman, J, Chazin, D, Georgescu, B. Feasibility and acceptance of a nonpharmacological cognitive remediation intervention for patients with Parkinson disease. J Geriatr Psychiatry Neurol 2011; 24: 91–7.Google Scholar
Paris, AP, Saleta, HG, de la Cruz Crespo, Maraver M, et al. Blind randomized controlled study of the efficacy of cognitive training in Parkinson's disease. Mov Disord 2011; 26: 1251–8.CrossRefGoogle ScholarPubMed
Sammer, G, Reuter, I, Hullmann, K, Kaps, M, Vaitl, D. Training of executive functions in Parkinson's disease. J Neurol Sci 2006; 248: 115–19.Google Scholar
Sinforiani, E, Banchieri, L, Zucchella, C, Pacchetti, C, Sandrini, G. Cognitive rehabilitation in Parkinson's disease. Arch Gerontol Geriatr Suppl 2004 (9): 387–91.Google Scholar
Reuter, I, Mehnert, S, Sammer, G, Oechsner, M, Engelhardt, M. Efficacy of a multimodal cognitive rehabilitation including psychomotor and endurance training in Parkinson's disease. J Aging Res 2012; 2012: 235765.Google Scholar
Naismith, SL, Mowszowski, L, Diamond, , K, Lewis, SJ. Improving memory in Parkinson's disease: a healthy brain ageing cognitive training program. Mov Disord 2013; 28: 1097–103.Google Scholar
Nombela, C, Bustillo, PJ, Castell, PF, et al. Cognitive rehabilitation in Parkinson's disease: evidence from neuroimaging. Front Neurol 2011; 2: 82.Google Scholar
Pompeu, JE, Mendes, FA, Silva, KG, et al. Effect of Nintendo Wii-based motor and cognitive training on activities of daily living in patients with Parkinson's disease: a randomised clinical trial. Physiotherapy 2012; 98: 196–204.Google Scholar
Cruise, KE, Bucks, RS, Loftus, AM, et al. Exercise and Parkinson's: benefits for cognition and quality of life. Acta Neurol Scand 2011; 123: 13–19.CrossRefGoogle ScholarPubMed
Nocera, JR, Amano, S, Vallabhajosula, S, Hass, CJ. Tai Chi exercise to improve non-motor symptoms of Parkinson's disease. J Yoga Phys Ther 2013; 3: 10.4172/2157-7595.1000137.Google ScholarPubMed
Ridgel, AL, Muller, MD, Kim, CH, Fickes, EJ, Mera, TO. Acute effects of passive leg cycling on upper extremity tremor and bradykinesia in Parkinson's disease. Phys Sportsmed 2011; 39: 83–93.Google Scholar
Tabak, R, Aquije, G, Fisher, BE. Aerobic exercise to improve executive function in Parkinson disease: a case series. J Neurol Phys Ther 2013; 37: 58–64.Google Scholar
Tanaka, K, Quadros, AC Jr, Santos, RF, Stella, F, Gobbi, LT, Gobbi, S. Benefits of physical exercise on executive functions in older people with Parkinson's disease. Brain Cogn 2009; 69: 435–41.Google Scholar
Boggio, PS, Fregni, F, Bermpohl, F, et al. Effect of repetitive TMS and fluoxetine on cognitive function in patients with Parkinson's disease and concurrent depression. Mov Disord 2005; 20: 1178–84.Google Scholar
Boggio, PS, Ferrucci, R, Rigonatti, SP, et al. Effects of transcranial direct current stimulation on working memory in patients with Parkinson's disease. J Neurol Sci 2006; 249: 31–8.CrossRefGoogle ScholarPubMed
Epstein, CM, Evatt, ML, Funk, A, et al. An open study of repetitive transcranial magnetic stimulation in treatment-resistant depression with Parkinson's disease. Clin Neurophysiol, 2007; 118: 2189–94.Google Scholar
Pal, E, Nagy, F, Aschermann, Z, Balazs, E, Kovacs, N. The impact of left prefrontal repetitive transcranial magnetic stimulation on depression in Parkinson's disease: a randomized, double-blind, placebo-controlled study. Mov Disord 2010; 25: 2311–17.CrossRefGoogle ScholarPubMed
Sedlackova, S, Rektorova, I, Srovnalova, H, Rektor, I. Effect of high frequency repetitive transcranial magnetic stimulation on reaction time, clinical features and cognitive functions in patients with Parkinson's disease. J Neural Transm 2009; 116: 1093–101.Google Scholar
Srovnalova, H, Marecek, R, Rektorova, I. The role of the inferior frontal gyri in cognitive processing of patients with Parkinson's disease: a pilot rTMS study. Mov Disord 2011; 26: 1545–8.Google Scholar
Srovnalova, H, Marecek, R, Kubikova, R, Rektorova, I. The role of the right dorsolateral prefrontal cortex in the Tower of London task performance: repetitive transcranial magnetic stimulation study in patients with Parkinson's disease. Exp Brain Res 2012; 223: 251–7.Google Scholar
Furukawa, T, Izumi, S, Toyokura, M, Masakado, Y. Effects of low-frequency repetitive transcranial magnetic stimulation in Parkinson's disease. Tokai J Exp Clin Med 2009; 34: 63–71.Google Scholar
Fregni, F, Santos, CM, Myczkowski, ML, et al. Repetitive transcranial magnetic stimulation is as effective as fluoxetine in the treatment of depression in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 2004; 75: 1171–4.Google Scholar
Leroi, I, Brandt, J, Reich, SG, et al. Randomized placebo-controlled trial of donepezil in cognitive impairment in Parkinson's disease. Int J Geriatr Psychiatry 2004; 19: 1–8.Google Scholar
Ravina, B, Putt, M, Siderowf, A, et al. Donepezil for dementia in Parkinson's disease: a randomised, double blind, placebo controlled, crossover study. J Neurol Neurosurg Psychiatry 2005; 76: 934–9.Google Scholar
Trail, M, Protas, EJ, Lai, E (eds). Neurorehabilitation in Parkinson's disease: An Evidence-based Treatment Model. New Jersey: SLACK, Inc. 2008Google Scholar
Cicerone, KD, Dahlberg, C, Malec, JF, et al. Evidence-based cognitive rehabilitation: updated review of the literature from 1998 through 2002. Arch Phys Med Rehabil 2005; 86: 1681–92.Google Scholar
Loewenstein, DA, Acevedo, A, Czaja, SJ, Duara, R. Cognitive rehabilitation of mildly impaired Alzheimer disease patients on cholinesterase inhibitors. Am J Geriatr Psychiatry 2004; 12: 395–402.Google Scholar
Jean, L, Bergeron, ME, Thivierge, S, Simard, M. Cognitive intervention programs for individuals with mild cognitive impairment: systematic review of the literature. Am J Geriatr Psychiatry 2010; 18: 281–96.Google Scholar
Hindle, JV, Petrelli, A, Clare, L, Kalbe, E. Nonpharmacological enhancement of cognitive function in Parkinson's disease: a systematic review. Mov Disord 2013; 28: 1034–49.Google Scholar
Twamley, EW, Savla, GN, Zurhellen, CH, Heaton, RK, Jeste, DV. Development and pilot testing of a novel compensatory cognitive training intervention for people with psychosis. Am J Psychiatr Rehabil 2008; 11: 144–63.Google Scholar
Olazaran, J, Muniz, R, Reisberg, B, et al. Benefits of cognitive-motor intervention in MCI and mild to moderate Alzheimer disease. Neurology 2004; 63: 2348–53.Google Scholar
Bronnick, K, Emre, M, Lane, R, Tekin, S, Aarsland, D. Profile of cognitive impairment in dementia associated with Parkinson's disease compared with Alzheimer's disease. J Neurol Neurosurg Psychiatry 2007; 78: 1064–8.CrossRefGoogle ScholarPubMed
Achtman, RL, Green, CS, Bavelier, D. Video games as a tool to train visual skills. Restor Neurol Neurosci 2008; 26: 435–46.Google Scholar
Nasreddine, ZS, Phillips, NA, Bedirian, V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005; 53: 695–9.Google Scholar
Scatton, B, Javoy-Agid, F, Rouquier, L, Dubois, B, Agid, Y. Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease. Brain Res 1983; 275: 321–8.Google Scholar
Colcombe, SJ, Erickson, KI, Scalf, PE, et al. Aerobic exercise training increases brain volume in aging humans. J Gerontol A Biol Sci Med Sci 2006; 61: 1166–70.Google Scholar
Tanaka, H, Koenig, T, Pascual-Marqui, RD, et al. Event-related potential and EEG measures in Parkinson's disease without and with dementia. Dement Geriatr Cogn Disord 2000; 11: 39–45.Google Scholar
Barnikol, TT, Barnikol, UB, Kuhn, J, Lenartz, D, Tass, PA. Changes in apraxia after deep brain stimulation of the nucleus basalis meynert in a patient With Parkinson dementia syndrome. Mov Disord 2010; 25: 1519–20.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×